Type to search

Global News

Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY ® in Children 5 to under 12 Years of Age in the European Union | Pharmtech Focus
Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients | Pharmtech Focus
Starpharma Releases Positive DEP® Cabazitaxel Phase 2 Interim Results in Prostate Cancer | Pharmtech Focus

Subscribe to our Newsletter

Be the first to know with our FREE industry newsletter, delivered direct to your inbox!

Follow our Social Feeds

Global News

Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY ® in Children 5 to under 12 Years of Age in the European Union | Pharmtech Focus
Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients | Pharmtech Focus
Starpharma Releases Positive DEP® Cabazitaxel Phase 2 Interim Results in Prostate Cancer | Pharmtech Focus